ID   DGLB_HUMAN              Reviewed;         672 AA.
AC   Q8NCG7; A4D2P3; B3KV90; B4DQU0; Q6PIX3; Q8N2N2; Q8N9S1; Q8TED3; Q8WXE6;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 2.
DT   28-JUN-2023, entry version 156.
DE   RecName: Full=Diacylglycerol lipase-beta {ECO:0000303|PubMed:14610053};
DE            Short=DAGL-beta {ECO:0000303|PubMed:14610053};
DE            Short=DGL-beta;
DE            EC=3.1.1.116 {ECO:0000269|PubMed:14610053};
DE   AltName: Full=KCCR13L;
DE   AltName: Full=PUFA-specific triacylglycerol lipase {ECO:0000250|UniProtKB:Q91WC9};
DE            EC=3.1.1.3 {ECO:0000250|UniProtKB:Q91WC9};
DE   AltName: Full=Sn1-specific diacylglycerol lipase beta {ECO:0000303|PubMed:14610053};
GN   Name=DAGLB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RA   Morimura S., Yasumoto S.;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4), AND VARIANT
RP   ARG-664.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ARG-664.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF SER-443 AND ASP-495, CATALYTIC
RP   ACTIVITY, AND ACTIVE SITE.
RX   PubMed=14610053; DOI=10.1083/jcb.200305129;
RA   Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A.,
RA   Matias I., Schiano-Moriello A., Paul P., Williams E.-J., Gangadharan U.,
RA   Hobbs C., Di Marzo V., Doherty P.;
RT   "Cloning of the first sn1-DAG lipases points to the spatial and temporal
RT   regulation of endocannabinoid signaling in the brain.";
RL   J. Cell Biol. 163:463-468(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-584, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570 AND SER-574, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-570 AND SER-579, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-574 AND SER-579, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Lipase that catalyzes the hydrolysis of arachidonic acid
CC       (AA)-esterified diacylglycerols (DAGs) to produce the principal
CC       endocannabinoid, 2-arachidonoylglycerol (2-AG) which can be further
CC       cleaved by downstream enzymes to release arachidonic acid (AA) for
CC       cyclooxygenase (COX)-mediated eicosanoid production (PubMed:14610053).
CC       Preferentially hydrolyzes DAGs at the sn-1 position in a calcium-
CC       dependent manner and has negligible activity against other lipids
CC       including monoacylglycerols and phospholipids (PubMed:14610053). Plays
CC       a key role in the regulation of 2-AG and AA pools utilized by COX1/2 to
CC       generate lipid mediators of macrophage and microglia inflammatory
CC       responses. Functions also as a polyunsaturated fatty acids-specific
CC       triacylglycerol lipase in macrophages. Plays an important role to
CC       support the metabolic and signaling demands of macrophages (By
CC       similarity). {ECO:0000250|UniProtKB:Q91WC9,
CC       ECO:0000269|PubMed:14610053}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + H2O = a 2-acylglycerol + a fatty
CC         acid + H(+); Xref=Rhea:RHEA:33275, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17389, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:28868; EC=3.1.1.116;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33276;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + H2O = 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:38507, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:52392,
CC         ChEBI:CHEBI:75728; Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38508;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + H2O = (9Z)-
CC         octadecenoate + 2-(9Z-octadecenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:38511, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:52333, ChEBI:CHEBI:73990;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38512;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycerol + H2O = (9Z)-octadecenoate + 2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-glycerol + H(+); Xref=Rhea:RHEA:38515,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:52392, ChEBI:CHEBI:75449;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38516;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycerol + H2O = (9Z)-
CC         octadecenoate + 2-octadecanoylglycerol + H(+); Xref=Rhea:RHEA:38519,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75448, ChEBI:CHEBI:75456;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38520;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol +
CC         H2O = (9Z)-octadecenoate + 2-(9Z,12Z-octadecadienoyl)-glycerol +
CC         H(+); Xref=Rhea:RHEA:38523, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75450, ChEBI:CHEBI:75457;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38524;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-O-(5Z,8Z,11Z,14Z-eicosatetraenyl)-sn-
CC         glycerol + H2O = (9Z)-octadecenoate + 2-O-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenylglycerol + H(+); Xref=Rhea:RHEA:38527,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75913, ChEBI:CHEBI:75914;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38528;
CC         Evidence={ECO:0000305|PubMed:14610053};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H2O =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoate + a di-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-glycerol + H(+); Xref=Rhea:RHEA:63432,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:147308, ChEBI:CHEBI:147309;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63433;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycerol + H2O =
CC         (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + a di-
CC         (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:63436, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:77016, ChEBI:CHEBI:147310, ChEBI:CHEBI:147311;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:14610053};
CC   -!- ACTIVITY REGULATION: Inhibited by the 1,2,3-triazole urea covalent
CC       inhibitors KT109 and KT172 (By similarity). Inhibited by p-hydroxy-
CC       mercuri-benzoate and HgCl(2), but not by PMSF. Also inhibited by
CC       RHC80267, a drug that blocks 2-AG formation.
CC       {ECO:0000250|UniProtKB:Q91WC9, ECO:0000269|PubMed:14610053}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=74.1 uM for diacylglycerol {ECO:0000269|PubMed:14610053};
CC         Vmax=3.45 nmol/min/mg enzyme {ECO:0000269|PubMed:14610053};
CC       pH dependence:
CC         Optimum pH is 7.0. {ECO:0000269|PubMed:14610053};
CC   -!- INTERACTION:
CC       Q8NCG7; Q92989: CLP1; NbExp=3; IntAct=EBI-721948, EBI-2559831;
CC       Q8NCG7; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-721948, EBI-22310682;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14610053};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NCG7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NCG7-2; Sequence=VSP_020245;
CC       Name=3;
CC         IsoId=Q8NCG7-3; Sequence=VSP_020246, VSP_020247;
CC       Name=4;
CC         IsoId=Q8NCG7-4; Sequence=VSP_043309;
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB85017.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF450090; AAL47020.1; -; mRNA.
DR   EMBL; AK093958; BAC04258.1; -; mRNA.
DR   EMBL; AK074210; BAB85017.1; ALT_INIT; mRNA.
DR   EMBL; AK122748; BAG53702.1; -; mRNA.
DR   EMBL; AK298955; BAG61052.1; -; mRNA.
DR   EMBL; AK074584; BAC11073.1; -; mRNA.
DR   EMBL; AK074744; BAC11175.1; -; mRNA.
DR   EMBL; AK075128; BAC11420.1; -; mRNA.
DR   EMBL; AC009412; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC072052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH878731; EAW55033.1; -; Genomic_DNA.
DR   EMBL; CH878731; EAW55035.1; -; Genomic_DNA.
DR   EMBL; CH236963; EAL23721.1; -; Genomic_DNA.
DR   EMBL; BC027603; AAH27603.1; -; mRNA.
DR   CCDS; CCDS47536.1; -. [Q8NCG7-4]
DR   CCDS; CCDS5350.1; -. [Q8NCG7-1]
DR   RefSeq; NP_001136408.1; NM_001142936.1. [Q8NCG7-4]
DR   RefSeq; NP_631918.3; NM_139179.3. [Q8NCG7-1]
DR   AlphaFoldDB; Q8NCG7; -.
DR   SMR; Q8NCG7; -.
DR   BioGRID; 128772; 69.
DR   IntAct; Q8NCG7; 26.
DR   STRING; 9606.ENSP00000297056; -.
DR   BindingDB; Q8NCG7; -.
DR   ChEMBL; CHEMBL5521; -.
DR   DrugCentral; Q8NCG7; -.
DR   GuidetoPHARMACOLOGY; 1397; -.
DR   SwissLipids; SLP:000000322; -.
DR   ESTHER; human-DAGLB; Lipase_3.
DR   iPTMnet; Q8NCG7; -.
DR   PhosphoSitePlus; Q8NCG7; -.
DR   SwissPalm; Q8NCG7; -.
DR   BioMuta; DAGLB; -.
DR   DMDM; 114149272; -.
DR   EPD; Q8NCG7; -.
DR   jPOST; Q8NCG7; -.
DR   MassIVE; Q8NCG7; -.
DR   MaxQB; Q8NCG7; -.
DR   PaxDb; Q8NCG7; -.
DR   PeptideAtlas; Q8NCG7; -.
DR   ProteomicsDB; 72891; -. [Q8NCG7-1]
DR   ProteomicsDB; 72892; -. [Q8NCG7-2]
DR   ProteomicsDB; 72893; -. [Q8NCG7-3]
DR   ProteomicsDB; 72894; -. [Q8NCG7-4]
DR   Antibodypedia; 24853; 119 antibodies from 21 providers.
DR   DNASU; 221955; -.
DR   Ensembl; ENST00000297056.11; ENSP00000297056.6; ENSG00000164535.15. [Q8NCG7-1]
DR   Ensembl; ENST00000425398.6; ENSP00000391171.2; ENSG00000164535.15. [Q8NCG7-4]
DR   GeneID; 221955; -.
DR   KEGG; hsa:221955; -.
DR   MANE-Select; ENST00000297056.11; ENSP00000297056.6; NM_139179.4; NP_631918.3.
DR   UCSC; uc003sqa.4; human. [Q8NCG7-1]
DR   AGR; HGNC:28923; -.
DR   CTD; 221955; -.
DR   DisGeNET; 221955; -.
DR   GeneCards; DAGLB; -.
DR   HGNC; HGNC:28923; DAGLB.
DR   HPA; ENSG00000164535; Low tissue specificity.
DR   MIM; 614016; gene.
DR   neXtProt; NX_Q8NCG7; -.
DR   OpenTargets; ENSG00000164535; -.
DR   PharmGKB; PA162383203; -.
DR   VEuPathDB; HostDB:ENSG00000164535; -.
DR   eggNOG; KOG2088; Eukaryota.
DR   GeneTree; ENSGT00940000156486; -.
DR   HOGENOM; CLU_008300_2_1_1; -.
DR   InParanoid; Q8NCG7; -.
DR   OMA; GRRWNIA; -.
DR   OrthoDB; 373802at2759; -.
DR   PhylomeDB; Q8NCG7; -.
DR   TreeFam; TF312928; -.
DR   BioCyc; MetaCyc:ENSG00000164535-MON; -.
DR   BRENDA; 3.1.1.116; 2681.
DR   PathwayCommons; Q8NCG7; -.
DR   Reactome; R-HSA-426048; Arachidonate production from DAG.
DR   SABIO-RK; Q8NCG7; -.
DR   SignaLink; Q8NCG7; -.
DR   SIGNOR; Q8NCG7; -.
DR   BioGRID-ORCS; 221955; 13 hits in 1153 CRISPR screens.
DR   ChiTaRS; DAGLB; human.
DR   GenomeRNAi; 221955; -.
DR   Pharos; Q8NCG7; Tchem.
DR   PRO; PR:Q8NCG7; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q8NCG7; protein.
DR   Bgee; ENSG00000164535; Expressed in granulocyte and 165 other tissues.
DR   ExpressionAtlas; Q8NCG7; baseline and differential.
DR   Genevisible; Q8NCG7; HS.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0047372; F:acylglycerol lipase activity; TAS:Reactome.
DR   GO; GO:0016298; F:lipase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; IBA:GO_Central.
DR   GO; GO:0007405; P:neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0022008; P:neurogenesis; IBA:GO_Central.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; IBA:GO_Central.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISS:UniProtKB.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   CDD; cd00519; Lipase_3; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002921; Fungal_lipase-like.
DR   PANTHER; PTHR45792; DIACYLGLYCEROL LIPASE HOMOLOG-RELATED; 1.
DR   PANTHER; PTHR45792:SF2; DIACYLGLYCEROL LIPASE-BETA; 1.
DR   Pfam; PF01764; Lipase_3; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Membrane; Metal-binding; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..672
FT                   /note="Diacylglycerol lipase-beta"
FT                   /id="PRO_0000248350"
FT   TOPO_DOM        1..17
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        18..38
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        39..58
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        59..79
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        80..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..132
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        133..153
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        154..672
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        443
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:14610053"
FT   ACT_SITE        495
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000305|PubMed:14610053"
FT   MOD_RES         570
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231"
FT   MOD_RES         574
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         579
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         583
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WC9"
FT   MOD_RES         584
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         1..281
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020245"
FT   VAR_SEQ         140..310
FT                   /note="SWIIIAATVVSIIIVFDPLGGKMAPYSSAGPSHLDSHDSSQLLNGLKTAATS
FT                   VWETRIKLLCCCIGKDDHTRVAFSSTAELFSTYFSDTDLVPSDIAAGLALLHQQQDNIR
FT                   NNQEPAQVVCHAPGSSQEADLDAELENCHHYMQFAAAAYGWPLYIYRNPLTGLCRIGGD
FT                   C -> RTQIWCPATLRRASPCFISNRTISGTTKSLPRWSAMPQGAPS (in isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043309"
FT   VAR_SEQ         249..267
FT                   /note="IRNNQEPAQVVCHAPGSSQ -> TRATGNCPRNDGLTLLSLN (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020246"
FT   VAR_SEQ         268..672
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020247"
FT   VARIANT         664
FT                   /note="Q -> R (in dbSNP:rs2303361)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_027275"
FT   MUTAGEN         443
FT                   /note="S->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14610053"
FT   MUTAGEN         495
FT                   /note="D->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14610053"
FT   CONFLICT        270
FT                   /note="D -> Y (in Ref. 3; BAC11175)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        456
FT                   /note="L -> V (in Ref. 2; BAC04258)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        545
FT                   /note="T -> K (in Ref. 7; AAH27603)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   672 AA;  73732 MW;  AA953D737E0EFF44 CRC64;
     MPGMVLFGRR WAIASDDLVF PGFFELVVRV LWWIGILTLY LMHRGKLDCA GGALLSSYLI
     VLMILLAVVI CTVSAIMCVS MRGTICNPGP RKSMSKLLYI RLALFFPEMV WASLGAAWVA
     DGVQCDRTVV NGIIATVVVS WIIIAATVVS IIIVFDPLGG KMAPYSSAGP SHLDSHDSSQ
     LLNGLKTAAT SVWETRIKLL CCCIGKDDHT RVAFSSTAEL FSTYFSDTDL VPSDIAAGLA
     LLHQQQDNIR NNQEPAQVVC HAPGSSQEAD LDAELENCHH YMQFAAAAYG WPLYIYRNPL
     TGLCRIGGDC CRSRTTDYDL VGGDQLNCHF GSILHTTGLQ YRDFIHVSFH DKVYELPFLV
     ALDHRKESVV VAVRGTMSLQ DVLTDLSAES EVLDVECEVQ DRLAHKGISQ AARYVYQRLI
     NDGILSQAFS IAPEYRLVIV GHSLGGGAAA LLATMLRAAY PQVRCYAFSP PRGLWSKALQ
     EYSQSFIVSL VLGKDVIPRL SVTNLEDLKR RILRVVAHCN KPKYKILLHG LWYELFGGNP
     NNLPTELDGG DQEVLTQPLL GEQSLLTRWS PAYSFSSDSP LDSSPKYPPL YPPGRIIHLQ
     EEGASGRFGC CSAAHYSAKW SHEAEFSKIL IGPKMLTDHM PDILMRALDS VVSDRAACVS
     CPAQGVSSVD VA
//
